Deal Room

Past & Present Investments

 

Telogenomics

TeloView ®  is the most comprehensive telomere-based diagnostic platform in the industry, with over 25 clinical studies, over 140 peer-reviewed papers and over 3000 patients evaluated across multiple cancers and Alzheimer’s disease. Our lead applications are focused on unmet clinical needs in multiple myeloma. Telo Genomics announced a clinical collaboration with the Mayo Clinic to validate two important applications: to predict if patients with a pre-cursor to multiple myeloma will transition to active multiple myeloma and to predict if newly diagnosed patients will respond to first-line therapy.

 

Evolve Charging Corp

Evolve will capitalize on the “fuel where you are” opportunity and operate a large network of vehicle charging stations across the U.S., many of which will be found at unique destinations where people want to visit, such as casinos, resorts and hotels. These stations will attract unique drivers and the program will be supported by high-profile brands who target these consumers with ads shown on the charging units, our web site and app.

 

Thiogenesis Therapeutics

Thiogenesis Therapeutics is based in San Diego, Calif., and is an early stage biotech company. It has a small but experienced team that has an extensive history in developing orphan drugs, with expertise in research and development, clinical and regulatory affairs, and commercialization.

Thiogenesis Therapeutics is developing novel compounds that are based on thiols, thiol derivatives or S-H groups, which are organosulphur compounds. These compounds are known to have powerful anti-oxidant properties, as well as other therapeutic benefits.

 

Vizsla Silver Corp

Vizsla Silver is a Canadian mineral exploration and development company headquartered in Vancouver, BC, focused on advancing its flagship, 100%-owned Panuco silver-gold project located in Sinaloa, Mexico. To date, Vizsla Silver has completed over 130,000 meters of drilling at Panuco leading to the discovery of several new high-grade veins. With an ongoing fully funded +100,000-meter drill program, the Company is well positioned to deliver a maiden project resource in the first quarter of 2022 while in parallel continuing to explore the significant upside potential remaining in the district.

 

Sharc International Systems Inc.

Sharc International Systems is a world leader in energy recovery from the waste water sent down the drain every day. Sharc Energy’s systems recycle thermal energy from waste water, generating one of the most energy-efficient and economical systems for heating, cooling and hot water production for commercial, residential and industrial buildings.

 

Kingfisher Metals

Kingfisher Metals Corp. is a Canadian based exploration company focused on underexplored district-scale projects in British Columbia. Kingfisher has three 100% owned district-scale projects that offer potential exposure to high-grade gold, copper, silver, and zinc.

 

Xphyto

XPhyto Therapeutics Corp. is a bioscience accelerator focused on next-generation drug delivery, diagnostic, and new active pharmaceutical ingredient investment opportunities, including: precision transdermal and oral dissolvable drug formulations; rapid, low-cost infectious disease and oral health screening tests; and standardization of emerging active pharmaceutical ingredients for neurological applications, including psychedelic compounds and cannabinoids. The Company has research and development operations in North America and Europe, with an operational focus in Germany, and is currently focused on regulatory approval and commercialization of medical products for European markets.

 

LUXXFOLIO Holdings Inc.

LUXXFOLIO Holdings Inc. is a publicly-traded vertically-integrated digital asset company based in Canada. We operate an industrial scale cryptocurrency mining facility in the United States running off mostly renewable energy with a focus on the blockchain ecosystem and generation of digital assets. LUXXFOLIO provides a liquid alternative for exposure to digital assets for the broader capital markets.